back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-05 21:18 Tx date 2024-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,050,720
+437,800 vol $2.40 each |
2,146,500 | |
| Filed 2024-02-05 21:15 Tx date 2024-02-02 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-23,083.375
-9,982 vol $2.31 each |
1,735,121 | |
| Filed 2024-02-05 21:10 Tx date 2024-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+109,500 vol |
1,745,103 | |
| Filed 2023-02-06 20:29 Tx date 2023-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+82,200 vol |
1,635,603 | |
| Filed 2023-02-06 20:20 Tx date 2023-02-01 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$953,230
+328,700 vol $2.90 each |
1,708,700 | |
| Filed 2022-01-20 18:30 Tx date 2022-01-20 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$800,850
+285,000 vol $2.81 each |
1,380,000 | |
| Filed 2021-02-18 09:18 Tx date 2021-02-13 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,255,700
+290,000 vol $4.33 each |
1,095,000 | |
| Filed 2020-02-19 14:54 Tx date 2020-02-17 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
805,000 | |
| Filed 2019-03-05 Tx date 2019-03-01 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$662,650
+145,000 vol $4.57 each |
555,000 | |
| Filed 2018-04-17 Tx date 2018-04-16 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$832,000
+160,000 vol $5.20 each |
410,000 | |
| Filed 2017-10-04 Tx date 2017-10-03 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-10,000 vol |
1,553,403 | |
| Filed 2017-08-16 Tx date 2017-08-15 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Holder: Irrevocable Deed of Trust of Michael J. Sofia (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-30,000 vol |
171,412 | |
| Filed 2017-04-03 Tx date 2017-03-24 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$472,500
+150,000 vol $3.15 each |
250,000 | |
| Filed 2016-03-29 Tx date 2016-03-15 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$394,000
+100,000 vol $3.94 each |
100,000 | |
| Filed 2016-03-29 Tx date 2015-03-04 |
$ABUS
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-26 Tx date 2015-03-04 |
$TKMR
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Holder: Irrevocable Deed of Trust of Michael J. Sofia (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
201,412 | ||
| Filed 2016-01-26 Tx date 2015-03-04 |
$TKMR
Arbutus Biopharma Corporation |
Sofia, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,563,403 |